During the past decade, Johns Hopkins University conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins University" #1 sponsor was "Johns Hopkins University" with 2 trials, followed by "Smith & Nephew, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Duke University" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins University" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "University of Texas Southwestern Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins University" are "Arthritis, Rheumatoid" (1 trials), "Arthropathy" (1 trials), "Atrial Fibrillation" (1 trials), "Closed Fracture Proximal Humerus, Four Part" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Johns Hopkins University" in a lesser frequency.

Most popular intervention types in "Johns Hopkins University" are "Drug" (4 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Digital Engagement" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins University" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Johns Hopkins University". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Johns Hopkins University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".